Cannasouth Investor Relations Material
Latest events
Investor Day 2023
Cannasouth
H2 2023
29 Feb, 2024
Trading Update
23 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cannasouth Limited
Access all reports
Cannasouth Limited is a biopharmaceutical company focused on the research, development, and commercialization of medicinal cannabis products. The company operates in areas such as cannabinoid extraction, formulation, and clinical research to create therapeutic products for various health conditions. Cannasouth also engages in cultivation and processing through joint ventures, aiming to ensure high-quality, sustainably produced raw materials for its products. The company is headquartered in Hamilton, New Zealand, and its shares are listed on the NZX.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CBD
Country
🇳🇿 New Zealand